Clinical trial
Study of Oral Bexarotene in Combination With Photopheresis for Treatment of…
NCT00306969 · Boston University, Other · Completed
Key facts
| NCT number | NCT00306969 |
|---|---|
| Title | Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma |
| Official title | Phase I/II Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma |
| Lead sponsor | Boston University, Other |
| Collaborators | Ligand Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cutaneous T-Cell Lymphoma |
| Intervention type | Device, Drug |
| Interventions | bexarotene, photopheresis |
| Enrollment | 18 |
| Start date | Dec 1, 2001 |
| Completion | Apr 1, 2004 |
| First posted | Mar 27, 2006 |
| Last update posted | Mar 27, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: